Contact Us

+91 -9891818024
Contact Us

Costeff Syndrome

Costeff Syndrome

Costeff Syndrome, also known as 3- Methylglutaconic Aciduria Type III, is a neuro- ophthalmologic complaint that specifically targets the optical jitters and the motor pathways of the brain. Primarily affecting individualities of Iraqi Jewish descent, Costeff Syndrome manifests beforehand in life with progressive vision loss. The hallmark of Costeff Syndrome is the early onset of optical atrophy, which is constantly followed by movement diseases like choreoathetosis or spasticity. Because Costeff Syndrome is a progressive metabolic- inheritable condition, early recognition is vital to manage the complex requirements of the case as they transition into majority.

Normal fundus versus Costeff Syndrome optic atrophy fundus illustration

Causes

The underpinning cause of Costeff Syndrome is a mutation in the OPA3 gene, which is responsible for maintaining the integrity of the mitochondria within the optical nerve and rudimentary ganglia. When the OPA3 protein is imperfect, the mitochondria can not produce energy efficiently, leading to the cellular death specific to Costeff Syndrome. This inheritable failure results in the excretion of 3- methylglutaconic acid in the urine, a crucial biomarker used to identify Costeff Syndrome.

Symptoms

Vision loss in Costeff Syndrome generally begins before the age of ten, characterized by a gradational decline in clarity and an incapability to distinguish colors. Cases with Costeff Syndrome frequently develop a steady, bilateral optical reddishness. Beyond the optical symptoms, Costeff Syndrome also causes physical challenges, similar to a loss of collaboration (ataxia) and stiff muscles (spasticity). The combination of visual and motor properties makes Costeff Syndrome a particularly exhausting condition for long- term operation.

Opinion

Opinion is generally verified through a combination of urinary organic acid analysis and inheritable testing for the OPA3mutation. An ophthalmic evaluation of a case with Costeff Syndrome will show significant thinning of the retinal nerve fiber subcaste via OCT imaging. Neurological assessments are also conducted to cover the extrapyramidal symptoms that define the broader clinical picture of Costeff Syndrome.

Treatment- Stem Cell Remedy

Stem cell remedy represents a significant advancement in the operation of the mitochondrial failures seen in Costeff Syndrome. By introducing functionally robust cells, regenerative treatment aims to give the metabolic support that the case's own DNA can not give. This approach is specifically designed to cover the remaining axons in Costeff Syndrome from further decay. For individuals facing the binary challenges of Costeff Syndrome, stem cell remedy provides a visionary way to target the neural "energy extremity," seeking to save vision and ameliorate the overall quality of life.

    Let Our Experts Help You

    Translate »